Rolf M. Zinkernagel

Wikipedia open wikipedia design.

Rolf Zinkernagel
Rolf Zinkernagel Erudite Conclave medical college trivandrum.jpg
Zinkernagel in 2011
BornRolf Martin Zinkernagel
(1944-01-06) January 6, 1944 (age 74)
Riehen, Basel-Stadt, Switzerland
Alma mater
Known forCytotoxic T cells
Awards
Scientific career
FieldsImmunology
InstitutionsUniversity of Zurich
ThesisThe role of the H-2 gene complex in cell-mediated immunity to viral and bacterial infections in mice (1975)
Websitewww.immunology.uzh.ch/aboutus/emeriti/zinkernagel.html
Signature
Rolf M. Zinkernagel.svg

Rolf Martin Zinkernagel AC, FAA (born January 6, 1944) is Professor of Experimental Immunology at the University of Zurich. He was awarded the Nobel Prize in Physiology or Medicine in 1996 for the discovery of how the immune system recognizes virus-infected cells. [4][5]

Education[edit]

Zinkernagel received his MD degree from the University of Basel in 1970 and his PhD from the Australian National University in 1975.[6]

Career and research[edit]

Zinkernagel is a member of the Cancer Research Institute Scientific Advisory Council, The National Academy of Sciences, and The Academy of Cancer Immunology. Zinkernagel was elected as a Corresponding Fellow to the Australian Academy of Science also in 1996.

Awards and honours[edit]

Together with the Australian Peter C. Doherty he received the 1996 Nobel Prize in Physiology or Medicine for the discovery of how the immune system recognizes virus-infected cells. With this he became the 24th Swiss Nobel laureate. In 1999 he was awarded an honorary Companion of the Order of Australia (AC), Australia's highest civilian honour, for his scientific work with Doherty.[7]

Viruses infect host cells and reproduce inside them. Killer T-cells destroy those infected cells so that the viruses can't reproduce. Zinkernagel and Doherty discovered that, in order for killer T-cells to recognize infected cells, they had to recognize two molecules on the surface of the cell—not only the virus antigen, but also a molecule of the major histocompatibility complex (MHC). This recognition was done by a T-cell receptor on the surface of the T-cell. The MHC was previously identified as being responsible for the rejection of incompatible tissues during transplantation. Zinkernagel and Doherty discovered that the MHC was responsible for the body fighting meningitis viruses too.[8]

In addition to the Nobel Prize, he also won the Cloëtta Prize in 1981, the Cancer Research Institute William B. Coley Award in 1987 and the Albert Lasker Medical Research Award in 1995. Zinkernagel was elected a Foreign Member of the Royal Society (ForMeRS) in 1998.[2][3]

References[edit]

  1. ^ Louis-Jeantet Prize
  2. ^ a b "Fellows of the Royal Society". London: Royal Society. Archived from the original on 2015-03-16.
  3. ^ a b "Fellowship of the Royal Society 1660-2015". Royal Society. Archived from the original on 2015-07-15.
  4. ^ Nobel Prize Autobiography
  5. ^ Hämmerling, GJ. (Jan 1997). "The 1996 Nobel Prize to Rolf Zinkernagel and Peter Doherty". Cell Tissue Res. 287 (1): 1–2. doi:10.1007/s004410050726. PMID 9011383.
  6. ^ Zinkernagel, Rolf (1975). The role of the H-2 gene complex in cell-mediated immunity to viral and bacterial infections in mice (PhD thesis). Australian National University.
  7. ^ It's an Honour: AC
  8. ^ The Nobel Prize in Physiology or Medicine 1996 -- Illustrated Presentation


This page is based on a Wikipedia article written by contributors (read/edit).
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

Destek